INMB Long Call Strategy
INMB (INmune Bio, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
INMB (INmune Bio, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $38.8M, a beta of 1.05 versus the broader market, a 52-week range of 1.09-11.64, average daily share volume of 408K, a public-listing history dating back to 2019, approximately 13 full-time employees. These structural characteristics shape how INMB stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.05 places INMB roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on INMB?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current INMB snapshot
As of May 15, 2026, spot at $1.57, ATM IV 127.70%, IV rank 19.53%, expected move 36.61%. The long call on INMB below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on INMB specifically: INMB IV at 127.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a INMB long call, with a market-implied 1-standard-deviation move of approximately 36.61% (roughly $0.57 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated INMB expiries trade a higher absolute premium for lower per-day decay. Position sizing on INMB should anchor to the underlying notional of $1.57 per share and to the trader's directional view on INMB stock.
INMB long call setup
The INMB long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With INMB near $1.57, the first option leg uses a $1.57 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed INMB chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 INMB shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.57 | N/A |
INMB long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
INMB long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on INMB. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on INMB
Long calls on INMB express a bullish thesis with defined risk; traders use them ahead of INMB catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
INMB thesis for this long call
The market-implied 1-standard-deviation range for INMB extends from approximately $1.00 on the downside to $2.14 on the upside. A INMB long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current INMB IV rank near 19.53% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on INMB at 127.70%. As a Healthcare name, INMB options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to INMB-specific events.
INMB long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. INMB positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move INMB alongside the broader basket even when INMB-specific fundamentals are unchanged. Long-premium structures like a long call on INMB are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current INMB chain quotes before placing a trade.
Frequently asked questions
- What is a long call on INMB?
- A long call on INMB is the long call strategy applied to INMB (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With INMB stock trading near $1.57, the strikes shown on this page are snapped to the nearest listed INMB chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are INMB long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the INMB long call priced from the end-of-day chain at a 30-day expiry (ATM IV 127.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a INMB long call?
- The breakeven for the INMB long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current INMB market-implied 1-standard-deviation expected move is approximately 36.61%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on INMB?
- Long calls on INMB express a bullish thesis with defined risk; traders use them ahead of INMB catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current INMB implied volatility affect this long call?
- INMB ATM IV is at 127.70% with IV rank near 19.53%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.